Glucotrack EPS GCTK
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- $22.80
- −92% on a year earlier
- Fiscal year 2023
- −$126.00
Glucotrack's twelve-month earnings per share can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was $22.80, down 92% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2023 | −$126.00 | n/a |
| FY2021 | −$1890.00 | n/a |
| FY2020 | −$630.00 | n/a |
| FY2019 | −$3510.00 | n/a |
| FY2018 | −$390780.00 | n/a |
| FY2017 | −$106470.00 | n/a |
| FY2016 | −$126360.00 | n/a |
| FY2015 | −$135720.00 | −474% |
| FY2014 | $36270.00 | n/a |
| FY2013 | −$235170.00 | n/a |
| FY2012 | −$60840.00 | n/a |
| FY2011 | −$4680.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $22.80 | −92% | n/a | |
| Q1 FY26 | $79.50 | −93% | n/a | |
| Q3 FY25 | $139.20 | −100% | n/a | |
| Q2 FY25 | $288.60 | −99% | n/a | |
| Q1 FY25 | $1204.20 | n/a | n/a | |
| Q3 FY24 | $32760.00 | n/a | $42156.00 | |
| Q2 FY24 | $29520.00 | +5974% | $8514.00 | |
| Q1 FY24 | −$21114.00 | n/a | −$20520.00 | |
| Q4 FY23 | $990.00 | n/a | −$126.00 | |
| Q3 FY23 | −$882.00 | n/a | n/a | |
| Q2 FY23 | $486.00 | n/a | n/a | |
| Q1 FY23 | −$720.00 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Glucotrack's size, closest first, today.
| Company | EPS, 12 months |
|---|---|
| GCTKGlucotrack | n/m |
| PFSAProfusa | n/m |
| BJDXBluejay Diagnostics | −$34.72 |
| VJETFlyte Aviation | n/m |
| IVFINVO Fertility | n/m |
| BBLGBone Biologics | −$1.41 |
| TNONTenon Medical | −$25.65 |
| AMIXAutonomix Medical | n/m |
| NXGLNexgel | −$14.20 |
| ADGMAdagio Medical | −$1.43 |
| XAIRBeyond Air | −$68.40 |
| Peer median | −$19.93 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Glucotrack
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.